R
Roberto Barriales-Villa
Researcher at University of A Coruña
Publications - 108
Citations - 2126
Roberto Barriales-Villa is an academic researcher from University of A Coruña. The author has contributed to research in topics: Hypertrophic cardiomyopathy & Cardiomyopathy. The author has an hindex of 20, co-authored 88 publications receiving 1243 citations. Previous affiliations of Roberto Barriales-Villa include Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Iacopo Olivotto,Artur Oreziak,Roberto Barriales-Villa,Theodore P. Abraham,Ahmad Masri,Pablo García-Pavía,Pablo García-Pavía,Sara Saberi,Neal K. Lakdawala,Matthew T. Wheeler,Anjali T. Owens,Milos Kubanek,Wojciech Wojakowski,Morten Kvistholm Jensen,Juan Ramón Gimeno-Blanes,Kia Afshar,Jonathan Myers,Jonathan Myers,Sheila M. Hegde,Scott D. Solomon,Amy J. Sehnert,David Zhang,Wanying Li,Mondira Bhattacharya,Jay M. Edelberg,Cynthia Burstein Waldman,Steven J. Lester,Andrew Wang,Carolyn Y. Ho,Daniel Jacoby,Jozef Bartunek,Antoine Bondue,Emeline Van Craenenbroeck,David Zemanek,Morten Søndergaard Jensen,Jens Mogensen,Jens Jakob Thune,Philippe Charron,Albert Hagège,Olivier Lairez,Jean Noël Trochu,Christoph Axthelm,Hans Dirk Duengen,Norbert Frey,Veselin Mitrovic,Michael Preusch,Jeanette Schulz-Menger,Tim Seidler,Michael Arad,Majdi Halabi,Amos Katz,Daniel Monakier,Offir Paz,Samuel Viskin,Donna R. Zwas,Hans-Peter Brunner-La Rocca,Michelle Michels,Dariusz Dudek,Zofia Oko-Sarnowska,Nuno Cardim,Helder Pereira,Pablo García Pavia,Juan Ramon Gimeno Blanes,Rafael Hidalgo Urbano,Luis Miguel Rincón Diaz,Perry M. Elliott,Zaheer Yousef,Theodore Abraham,Paulino Alvarez,Richard G. Bach,Richard C. Becker,Lubna Choudhury,David Fermin,John L. Jefferies,Christopher M. Kramer,Neal K. Lakdawala,Steven Lester,Ali J. Marian,Mathew S. Maurer,Sherif F. Nagueh,David R. Owens,Florian Rader,Mark V. Sherrid,Jamshid Shirani,John Symanski,Aslan T. Turer,Omar Wever-Pinzon,Timothy C. Wong,Mohamad H. Yamani +88 more
TL;DR: Treatment with mavacamten improved exercise capacity, LVOT obstruction, NYHA functional class, and health status in patients with obstructive hypertrophic cardiomyopathy and highlights the benefits of disease-specific treatment for this condition.
Journal ArticleDOI
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
Martin Ortiz-Genga,Sofía Cuenca,Matteo Dal Ferro,Esther Zorio,Ricardo Salgado-Aranda,Vicente Climent,Laura Padron-Barthe,Iria Duro-Aguado,Juan Jiménez-Jáimez,Víctor M. Hidalgo-Olivares,Enrique García-Campo,Chiara Lanzillo,M. Paz Suárez-Mier,Hagith Yonath,Sonia Marcos-Alonso,Juan Pablo Ochoa,José L. Santomé,Diego García-Giustiniani,Jorge Rodriguez-Garrido,Fernando Dominguez,Marco Merlo,Julián Palomino,Maria Luisa Peña,Juan Pablo Trujillo,Alicia Martín-Vila,Davide Stolfo,Pilar Molina,Enrique Lara-Pezzi,Francisco E. Calvo-Iglesias,Eyal Nof,Leonardo Calò,Roberto Barriales-Villa,Juan Ramón Gimeno-Blanes,Michael Arad,Pablo García-Pavía,Lorenzo Monserrat +35 more
TL;DR: In this article, the authors demonstrate the association between truncating mutations in the Filamin C (FLNC) gene and the development of high-risk dilated and arrhythmogenic cardiomyopathies.
Journal ArticleDOI
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)
Gabrielle Norrish,Gabrielle Norrish,T Ding,Ella Field,Ella Field,Lidia Ziółkowska,Iacopo Olivotto,Giuseppe Limongelli,Aristides Anastasakis,Robert G. Weintraub,Robert G. Weintraub,Elena Biagini,Luca Ragni,Terence Prendiville,Sophie Duignan,Karen McLeod,Maria Ilina,Adrián Fernández,Regina Bökenkamp,Anwar Baban,Peter Kubuš,Piers E.F. Daubeney,Georgia Sarquella-Brugada,Georgia Sarquella-Brugada,Sergi Cesar,Chiara Marrone,Vinay Bhole,Constancio Medrano,Orhan Uzun,Elspeth Brown,Ferran Gran,Francisco Castro,Graham Stuart,Gabriele Vignati,Roberto Barriales-Villa,Luis G Guereta,Satish Adwani,Katie Linter,Tara Bharucha,Pablo García-Pavía,Torsten Bloch Rasmussen,Margherita Calcagnino,Caroline Jones,Hans De Wilde,J Toru-Kubo,Tiziana Felice,Jens Mogensen,Sujeev Mathur,Zdenka Reinhardt,Constantinos O'Mahony,Constantinos O'Mahony,Perry M. Elliott,Perry M. Elliott,Rumana Z Omar,Juan Pablo Kaski,Juan Pablo Kaski +55 more
TL;DR: This new, validated risk stratification model for SCD in childhood HCM may provide individualized estimates of risk at 5 years using readily obtained clinical risk factors.
Journal ArticleDOI
Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations
Fernando Dominguez,Sofía Cuenca,Zofia T. Bilińska,Rocío Toro,Eric Villard,Roberto Barriales-Villa,Juan Pablo Ochoa,Folkert W. Asselbergs,Arjan Sammani,Maria Franaszczyk,Mohammed Shakil Akhtar,Maria José Coronado-Albi,Diego Rangel-Sousa,José Rodríguez-Palomares,Juan Jiménez-Jáimez,José Manuel García-Pinilla,Tomás Ripoll-Vera,Maria Victoria Mogollón-Jimenez,Ana Fontalba-Romero,Dolores Garcia-Medina,Julián Palomino-Doza,David de Gonzalo-Calvo,Marcos Cicerchia,Joel Salazar-Mendiguchía,Clara Salas,Sabine Pankuweit,Thomas Morris Hey,Jens Mogensen,Paul J.R. Barton,Philippe Charron,Perry M. Elliott,Pablo García-Pavía +31 more
TL;DR: DCM caused by mutations in BAG3 is characterized by high penetrance in carriers >40 years of age and a high risk of progressive heart failure.
Journal ArticleDOI
Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week.
Maurizio Pieroni,James C. Moon,Eloisa Arbustini,Roberto Barriales-Villa,Antonia Camporeale,Andreja Cokan Vujkovac,Perry M. Elliott,Albert Hagège,Johanna Kuusisto,Aleš Linhart,Peter Nordbeck,Iacopo Olivotto,Päivi Pietilä-Effati,Mehdi Namdar +13 more
TL;DR: In this paper, the authors suggest that in addition to Gb3 accumulation, other mechanisms contribute to the development of Fabry cardiomyopathy, suggesting a central role for myocardial inflammation and setting the stage for further research.